Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) from pre and asymptomatic infected individuals: a systematic review

被引:24
|
作者
Jefferson, Tom [1 ]
Spencer, Elizabeth A. [2 ]
Brassey, Jon [3 ]
Onakpoya, Igho J. [1 ]
Rosca, Elena C. [4 ]
Pluddemann, Annette [2 ]
Evans, David H. [5 ,6 ]
Conly, John M. [7 ,8 ,9 ,10 ,11 ,12 ]
Heneghan, Carl J. [2 ]
机构
[1] Univ Oxford, Dept Continuing Educ, Rewley House,1 Wellington Sq, Oxford OX1 2JA, England
[2] Univ Oxford, Ctr Evidence Based Med, Nuffield Dept Primary Care Hlth Sci, Oxford, England
[3] Trip Database Ltd, Newport, Gwent, Wales
[4] Victor Babes Univ Med & Pharm, Timisoara, Romania
[5] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada
[6] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada
[7] Univ Calgary, Dept Med, Synder Inst Chron Dis, Calgary, AB, Canada
[8] Univ Calgary, Dept Microbiol, Synder Inst Chron Dis, Calgary, AB, Canada
[9] Univ Calgary, Dept Immunol & Infect Dis, Synder Inst Chron Dis, Calgary, AB, Canada
[10] Univ Calgary, Dept Pathol & Lab Med, Synder Inst Chron Dis, Calgary, AB, Canada
[11] Univ Calgary, OBrien Inst Publ Hlth, Cumming Sch Med, Calgary, AB, Canada
[12] Alberta Hlth Serv, Calgary, AB, Canada
关键词
Asymptomatic cases; Levels of evidence; Presymptomatic cases; SARS-CoV-2; Transmission;
D O I
10.1016/j.cmi.2021.10.015
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: The role of SARS-Cov-2-infected persons who develop symptoms after testing (pre-symptomatics) or not at all (asymptomatics) in the pandemic spread is unknown. Objectives: To determine infectiousness and probable contribution of asymptomatic persons (at the time of testing) to pandemic SARS-CoV-2 spread. Data sources: LitCovid, medRxiv, Google Scholar, and WHO Covid-19 databases (to 31 March 2021) and references in included studies. Study eligibility criteria: Studies with a proven or hypothesized transmission chain based either on serial PCR cycle threshold readings and/or viral culture and/or gene sequencing, with adequate follow-up. Participants: People exposed to SARS-CoV-2 within 2-14 days to index asymptomatic (at time of observation) infected individuals. Interventions: Reliability of symptom and signs was assessed within contemporary knowledge; trans-mission likelihood was assessed using adapted causality criteria. Methods: Systematic review. We contacted all included studies' corresponding authors requesting further details. Results: We included 18 studies from a diverse setting with substantial methodological variation (this field lacks standardized methodology). At initial testing, prevalence of asymptomatic cases was 12.5-100%. Of these, 6-100% were later determined to be presymptomatic, this proportion varying according to setting, methods of case ascertainment and population. Nursing/care home facilities reported high rates of presymptomatic: 50-100% (n = 3 studies). Fourteen studies were classified as high risk of, and four studies as at moderate risk of symptom ascertainment bias. High-risk studies may be less likely to distinguish between presymptomatic and asymptomatic cases. Six asymptomatic studies and four pre-symptomatic studies reported culturing infectious virus; data were too sparse to determine infectious-ness duration. Three studies provided evidence of possible and three of probable/likely asymptomatic transmission; five studies provided possible and two probable/likely presymptomatic SARS-CoV-2 transmission. Conclusion: High-quality studies provide probable evidence of SARS-CoV-2 transmission from pre-symptomatic and asymptomatic individuals, with highly variable estimated transmission rates. (C) 2021 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
引用
收藏
页码:178 / 189
页数:12
相关论文
共 50 条
  • [1] severe Acute Respiratory Syndrome Coronavirus-2 SARS-CoV-2 An Update
    Pal, Mahendra
    Berhanu, Gemechu
    Desalegn, Chaltu
    Kandi, Venkataramana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (03)
  • [2] Transmission of SARS-CoV-2 from pre and asymptomatic infected individuals: a systematic review update
    Jefferson, Tom
    Spencer, Elizabeth A.
    Onakpoya, Igho J.
    Pluddemann, Annette
    Conly, John M.
    Heneghan, Carl J.
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (11) : 1511 - 1512
  • [3] Dismantling myths on the airborne transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
    Tang, J. W.
    Bahnfleth, W. P.
    Bluyssen, P. M.
    Buonanno, G.
    Jimenez, J. L.
    Kurnitski, J.
    Li, Y.
    Miller, S.
    Sekhar, C.
    Morawska, L.
    Marr, L. C.
    Melikov, A. K.
    Nazaroff, W. W.
    Nielsen, P., V
    Tellier, R.
    Wargocki, P.
    Dancer, S. J.
    JOURNAL OF HOSPITAL INFECTION, 2021, 110 : 89 - 96
  • [4] Tracing the origin of Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): A systematic review and narrative synthesis
    Thakur, Nagendra
    Das, Sayak
    Kumar, Swatantra
    Maurya, Vimal K.
    Dhama, Kuldeep
    Paweska, Janusz T.
    Abdel-Moneim, Ahmed S.
    Jain, Amita
    Tripathi, Anil K.
    Puri, Bipin
    Saxena, Shailendra K.
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (12) : 5766 - 5779
  • [5] Re: Dismantling Myths on the Airborne Transmission of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2)
    不详
    JOURNAL OF UROLOGY, 2022, 207 (04): : 907 - 907
  • [6] Effect of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) on reproductive system
    Wang, Nengzhuang
    Qin, Lina
    Ma, Long
    Yan, Hongli
    STEM CELL RESEARCH, 2021, 52
  • [7] Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China
    Wang, Yubo
    He, Yong
    Tong, Jin
    Qin, Yalan
    Xie, Ting
    Li, Jianghua
    Li, Jianrong
    Xiang, Jianhua
    Cui, Yong
    Higgs, Elizabeth S.
    Xiang, Jianglin
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (16) : 2132 - 2138
  • [8] Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis, and Investigational Therapeutics
    Sharma, Rahul
    Khokhar, Dharmendra
    Gupta, Bhanushree
    Saxena, Purnendu
    Ghosh, Kallol Kumar
    Geda, Arvind Kumar
    Kuca, Kamil
    CURRENT MEDICINAL CHEMISTRY, 2021, 28 (41) : 8559 - 8594
  • [9] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
    Wei Feng
    Wei Zong
    Feng Wang
    Shaoqing Ju
    Molecular Cancer, 19
  • [10] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review
    Feng, Wei
    Zong, Wei
    Wang, Feng
    Ju, Shaoqing
    MOLECULAR CANCER, 2020, 19 (01)